Sherbrooke, Canada

Brigitte Guerin

This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents. Top assignee: Societe De Commercialisation Des Produits De La Recherche Appliquee Socpra Sciences Sante Et Humaines S.e.c.. Active years: 2022-2024.

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.4

ph-index = 1


Location History:

  • Sherbrooke, CA (2022)
  • Westbury, CA (2024)

Company Filing History:


Years Active: 2022-2024

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Brigitte Guerin: Innovator in Gallium-68 Production

Introduction

Brigitte Guerin is a notable inventor based in Westbury, California. She has made significant contributions to the field of radiopharmaceuticals, particularly in the production and purification of gallium-68, a radioisotope used in medical imaging.

Latest Patents

Brigitte Guerin holds a patent for "Processes and systems for producing and/or purifying gallium-68." This patent describes innovative processes that utilize two cation-exchange chromatography columns to effectively separate gallium from zinc and other impurities. The method achieves a high overall yield of gallium-68 while being compatible with its short half-life. Additionally, the process can be implemented through an automated system, enhancing efficiency in production.

Career Highlights

Brigitte is associated with the company Société de Commercialisation des Produits de la Recherche Appliquée (Socpra Sciences Santé et Humaines S.E.C.). Her work focuses on advancing techniques that improve the accessibility and quality of gallium-68 for medical applications.

Collaborations

Brigitte collaborates with talented individuals such as Sebastien Tremblay and Samia Ait-Mohand, contributing to a dynamic research environment that fosters innovation.

Conclusion

Brigitte Guerin's work in the production and purification of gallium-68 represents a significant advancement in medical imaging technology. Her innovative approaches and collaborations continue to impact the field positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…